Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2021-12-13 Investor Presentation
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
公告本公司受元富證券邀請參加台股企業日說明營運概況。
Investor Presentation Classification · 85% confidence The document is a short announcement about the company (4119 旭富) being invited to participate in a corporate day event to explain its business overview. It includes details about the date, time, and location of the event and mentions that full financial and business information can be found elsewhere. The document does not contain actual financial statements or detailed financial analysis, nor is it a transcript or report itself. It is essentially a notice about an upcoming investor presentation event. Given the short length (623 characters) and the nature of the content, this fits best as an Investor Presentation (IP) announcement rather than the presentation materials themselves. However, since it is an announcement of the event and not the presentation materials, and considering the classification options, the closest match is Investor Presentation (IP) as it relates to the event focused on financials and business overview.
2021-12-13 Chinese
110年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, showing zero balances for fund loans and endorsements/guarantees for the current and previous months. It contains no detailed financial statements or analysis, nor does it mention any report publication or regulatory certification. The content is a regulatory disclosure of financial status related to loans and guarantees, typical of a general regulatory announcement rather than a full report or announcement of a report. The document length is short (601 characters), and it does not indicate it is an announcement of a report publication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-12-08 Chinese
110年11月營業收入
Regulatory Filings Classification · 95% confidence The document is a revenue summary report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes and explanations for significant changes. It is a brief financial data disclosure, typical of a regulatory announcement or a financial summary update. The document length is only 802 characters, and it does not contain comprehensive financial statements or detailed analysis. It also includes notes about accounting standards and reporting requirements but does not present a full financial report. Therefore, it is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth of a full report.
2021-12-08 Chinese
公告本公司高流動性資產、短期借款、應付短期票券及 一年內到期之長期負債。
Regulatory Filings Classification · 95% confidence The document is a short announcement from a listed company (4119 旭富) providing specific financial data related to high liquidity assets, short-term borrowings, short-term notes payable, and long-term liabilities due within one year as of October 2021. It references a regulatory clause (第 51 款) and a regulatory letter number, indicating compliance with disclosure requirements. The document length is only 785 characters, and it does not contain comprehensive financial statements or detailed analysis. It is a regulatory announcement of financial information rather than a full financial report or audit. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance disclosures that do not fit other specific categories.
2021-11-19 Chinese
110年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by company insiders, including directors, supervisors, and managers, showing their current and pledged shares. It includes specific data on share counts and relationships but does not contain financial statements, earnings data, or management discussion. The content is focused on insider shareholdings and their changes, which aligns with reporting on personal share transactions or holdings by company directors and executives. There is no indication of a full report, earnings release, or regulatory announcement. The document length is 3148 characters, which is relatively short but contains detailed insider shareholding data. Therefore, the best fitting category is Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2021-11-09 Chinese
110年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows changes in shareholdings, stock types, and notes on identities. The content is focused on insider shareholding disclosures rather than financial results, management changes, or meeting materials. There is no indication of a report publication or announcement, nor is it a transcript or legal proceeding. This type of document aligns with the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data, not just an announcement or certification.
2021-11-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.